佐藤一也 (Kazuya Sato) - マイポータル - researchmap

基本情報

所属: 旭川医科大学内科学講座消化器・血液腫瘍制御内科学分野講師

学位: 博士（医学）(旭川医科大学)

J-GLOBAL ID: 200901026774798053
researchmap会員ID: 5000066842

研究キーワード

8

研究分野

1

ライフサイエンス / 血液、腫瘍内科学 /

経歴

1

2001年4月 - 2003年3月

Research Fellow in Department of Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX (2001.4~2003.3)

学歴

3

MISC

25

Induction of leukemia-specific antibodies by immunotherapy with leukemia-cell-derived heat shock protein 70

Junko Jimbo, Kazuya Sato, Takaaki Hosoki, Motohiro Shindo, Katsuya Ikuta, Yoshihiro Torimoto, Yutaka Kohgo

CANCER SCIENCE 99(7) 1427-1434 2008年7月
A novel five-way chromosomal translocation observed in chronic myelogenous leukemia

Katsuya Ikuta, Yoshihiro Torimotoa, Junko Jimbo, Junki Inamura, Takaaki Hosoki, Motohirc Shindo, Kazuya Sato, Hiroyuki Takahashi, Yutaka Kohgo

CANCER GENETICS AND CYTOGENETICS 183(1) 69-71 2008年5月
Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, Nishikawa T, Nakano Y, Yanagawa N, Sato K, Maemoto A, Tanno S, Okumura T, Karasaki H, Kono T, Fujiya M, Ashida T, Chung DC, Kohgo Y.Sonic hedgehog derived from human pancreatic cancer ce・・・

Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, Nishikawa T, Nakano Y, Yanagawa N, Sato K …

Cancer Sci. 99(6) 1131-1138 2008年
Shindo M, Sato K, Jimbo J, Hosoki T, Ikuta K, Sano A, Nishimura K, Torimoto Y, Kohgo Y. Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia.

Shindo M, Sato K, Jimbo J, Hosoki T, Ikuta K, Sano A, Nishimura K, Torimoto Y, Kohgo Y

Rinsho Ketsueki 48(5) 412-417 2007年
Iuchi Y, Torimoto Y, Sato K, Tamura Y, Jimbo J, Inamura J, Shindo M, Ikuta K, Ohnishi K, Kohgo Y.Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residu・・・

Iuchi Y, Torimoto Y, Sato K, Tamura Y, Jimbo J, Inamura J, Shindo M, Ikuta K, Ohnishi K, Kohgo Y

Int J Hematol. 84(5) 449-458 2006年12月
Hashino S, Fujisawa F, Kondo T, Imamura M, Sato K, Torimoto Y, Kohgo Y, Kimura K, Furukawa H, Todo S, Asaka M. Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7 after allogeneic peripheral blood stem cell transplantation and liver transpla・・・

Hashino S, Fujisawa F, Kondo T, Imamura M, Sato K, Torimoto Y, Kohgo Y, Kimura K, Furukawa H, Todo S …

Int J Hematol 84(4) 363-366 2006年
Jimbo J, Sato K, Ikuta K, Inamura J, Hosoki T, Shindo M, Ohnishi K, Miyokawa N, Torimoto Y, Kohgo Y.A neuron specific enolase-producing multiple myeloma.

Jimbo J, Sato K, Ikuta K, Inamura J, Hosoki T, Shindo M, Ohnishi K, Miyokawa N, Torimoto Y, Kohgo Y

Rinsho Ketsueki 47(10) 1381-1386 2006年
Shindo M, Torimoto Y, Saito H, Motomura W, Ikuta K, Sato K, Fujimoto Y, Kohgo Y.Functional role of DMT1 in transferrin-independent iron uptake by human hepatocyte and hepatocellular carcinoma cell, HLF.

Shindo M, Torimoto Y, Saito H, Motomura W, Ikuta K, Sato K, Fujimoto Y, Kohgo Y

Hepatol Res. 35(3) 152-62 2006年
Upregulation of hepcidin by interleukin-1 beta in human hepatoma cell lines

J Inamura, K Ikuta, J Jimbo, M Shindo, K Sato, Y Torimoto, Y Kohgo

HEPATOLOGY RESEARCH 33(3) 198-205 2005年11月
Ohnishi K, Torimoto Y, Itabashi K, Inamura J, Shindo M, Ikuta K, Sato K, Kohgo Y.Case of intraspinal epidural tumor developing after systemic mastocytosis with marked osteosclerosis and myelofibrosis.

Ohnishi K, Torimoto Y, Itabashi K, Inamura J, Shindo M, Ikuta K, Sato K, Kohgo Y

Rinsho Ketsueki 46(10) 1146-1151 2005年
Ikuta K, Torimoto Y, Jimbo J, Inamura J, Shindo M, Sato K, Tokusashi Y, Miyokawa N, Kohgo Y.Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.

Ikuta K, Torimoto Y, Jimbo J, Inamura J, Shindo M, Sato K, Tokusashi Y, Miyokawa N, Kohgo Y

Int J Hematol. 82(4) 343-346 2005年
Iuchi Y, Sato K, Jimbo J, Inamura J, Shindo M, Ikuta K, Shinzaki H, Ohnishi K, Watanabe S, Torimoto Y, Kohgo Y.Acute lymphoblastic leukemia with t(4;11)(q21;q23) after iodine-131 treatment for thyroid cancer.

Iuchi Y, Sato K, Jimbo J, Inamura J, Shindo M, Ikuta K, Shinzaki H, Ohnishi K, Watanabe S, Torimoto Y …

Rinsho Ketsueki. 46(11) 1202-1207 2005年
Yamochi T, Yamochi T, Aytac U, Sato T, Sato K, Ohnuma K, McKee KS, Morimoto C, Dang NH.Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced・・・

Yamochi T, Yamochi T, Aytac U, Sato T, Sato K, Ohnuma K, McKee KS, Morimoto C, Dang NH

Cancer Res. 65(5) 1973-1983 2005年
Dang NH, Aytac U, Sato K, O'Brien S, Melenhorst J, Morimoto C, Barrett AJ, Molldrem JJ. T-large granular lymphocyte lymphoproliferative disorder. expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition.

Dang NH, Aytac U, Sato K, O'Brien S, Melenhorst J, Morimoto C, Barrett AJ, Molldrem JJ

Br J Haematol. 121(6) 857-65 2003年
Aytac U, Sato K, Yamochi T, Ohnuma K, Mills GB, Morimoto C, Dang NH. Effect of CD26/dipeptidyl peptidase Ⅳ on Jurkat sensitivity to G2/M arrest induced by topoisomerase Ⅱ inhibitors.

Aytac U, Sato K, Yamochi T, Ohnuma K, Mills GB, Morimoto C, Dang NH

Br J Cancer. 88(3) 455-62 2003年
Sato K, Dang NH. CD26: A novel treatment target for T-cell lymphoid malignancies? (Review)

Sato K, Dang NH

Int J Oncol. 22(3) 481-97 2003年
Sato K, Aytac U, Yamochi T, Yamochi T, Ohnuma K, McKee KS, Morinmoto C, Dang NH.CD26/dipeptidyl peptidase Ⅳ enhances expression of topoisomerase Ⅱ alpha and sensitivilty to apoptosis induced by topoisomerase Ⅱ inhibitors.

Sato K, Aytac U, Yamochi T, Yamochi T, Ohnuma K, McKee KS, Morinmoto C, Dang NH

Br J Cancer. 89(7) 1366-74 2003年
Dang NH, Aytac U, Sato K, O'Brien S, Melenhorst J, Morimoto C, Barrett AJ, Molldrem JJ. T-large granular lymphocyte lymphoproliferative disorder. expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition.

Br J Haematol. 121(6) 857-65 2003年
Aytac U, Sato K, Yamochi T, Ohnuma K, Mills GB, Morimoto C, Dang NH. Effect of CD26/dipeptidyl peptidase Ⅳ on Jurkat sensitivity to G2/M arrest induced by topoisomerase Ⅱ inhibitors. Br J Cancer.

88(3) 455-62 2003年
Sato K, Dang NH. CD26 : A novel treatment target for T-cell lymphoid malignancies? (Review)

Int J Oncol. 22(3) 481-97 2003年

もっとみる

講演・口頭発表等

7

A Novel Cytotoxic Mechanism by Leukemia-Specific Antibody in Immunotherapy with Leukemia Cell-Derived Heat Shock Protein 70.

49th Annual Meeting of the American Society of Hematology (Atlanta) 2007年
Increase of Anti-leukemia Effect of Leukemia cell-derived-HSP70 in a combined use of Dendritic Cells.

4th International Conference on Heat Shock Proteins in Immune Response (Farmington, CT, USA) 2004年
Combined Use of Dendritic Cells enhances Anti-leukemia Effect of Leukemia cell-derived-HSP70 in a Mouse Model with Minimal Residual Leukemia Cells.

46th Annual Meeting of the American Society of Hematology (San Diego) 2004年
Novel Immunotherapy using dendritic cell pulsed with heat shock protein preparations against mice with leukemia cells after syngeneic bone marrow transplantation.

45th Annual Meeting of the American Society of Hematology (San Diego) 2003年
Expression of CD26 and Its Intrinsic Dipeptidyl Peptidase IV (DPPIV) Enzyme Activity Enhances Sensitivity to Apoptosis Mediated by Topoisomerase II Inhibitors.

44th Annual Meeting of the American Society of Hematology (Philadelphia) 2002年
Induction of anti-leukemia cell immunity by heat shock protein preparations after syngeneic bone marrow transplantation in mice.

42th Annual Meeting of the American Society of Hematology 2000年
Novel immunotherapy using heat shock protein preparations of leukemic cells after syngeneic bone marrow transplantation in mice.

41th Annual Meeting of the American Society of Hematology 1999年

所属学協会

6

共同研究・競争的資金等の研究課題

2